Notice of Closed Meeting, 64528 [2019-25351]
Download as PDF
<![CDATA[
64528
Federal Register / Vol. 84, No. 226 / Friday, November 22, 2019 / Notices
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2019–25353 Filed 11–21–19; 8:45 am]
BILLING CODE 4163–18–P
khammond on DSKJM1Z7X2PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2013–N–1147]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Preparing a Claim
of Categorical Exclusion or an
Environmental Assessment for
Submission to the Center for Food
Safety and Applied Nutrition
Centers for Disease Control and
Prevention
AGENCY:
Notice of Closed Meeting
ACTION:
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting.
The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title
5 U.S.C., and the Determination of the
Director, Strategic Business Initiatives
Unit, Office of the Chief Operating
Officer, CDC, pursuant to Public Law
92–463.
Name of Committee: Safety and
Occupational Health Study Section
(SOHSS), National Institute for
Occupational Safety and Health
(NIOSH).
Date: February 19–20, 2020.
Time: 8:00 a.m.–5:00 p.m., EST.
Place: Embassy Suites, 1900 Diagonal
Road, Alexandria, VA 22314.
Agenda: The meeting will convene to
address matters related to the conduct of
Study Section business and for the
study section to consider safety and
occupational health-related grant
applications.
For Further Information Contact: Nina
Turner, Ph.D., Scientific Review Officer,
NIOSH, 1095 Willowdale Road,
Morgantown, WV 26506, (304) 285–
5976; nturner@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
SUMMARY:
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2019–25351 Filed 11–21–19; 8:45 am]
BILLING CODE 4163–18–P
VerDate Sep<11>2014
16:57 Nov 21, 2019
Jkt 250001
Food and Drug Administration,
HHS.
Notice.
The Food and Drug
Administration (FDA or we) is
announcing that a proposed collection
of information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by December
23, 2019.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, Fax: 202–
395–7285, or emailed to oira_
submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–0541. Also
include the FDA docket number found
in brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT:
Domini Bean, Office of Operations,
Food and Drug Administration, Three
White Flint North, 10A–12M, 11601
Landsdown St., North Bethesda, MD
20852, 301–796–5733, PRAStaff@
fda.hhs.gov.
In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
SUPPLEMENTARY INFORMATION:
Preparing a Claim of Categorical
Exclusion or an Environmental
Assessment for Submission to the
Center for Food Safety and Applied
Nutrition
OMB Control Number 0910–0541—
Extension
As an integral part of our decision
making process, we are obligated under
the National Environmental Policy Act
of 1969 (NEPA) to consider the
environmental impact of our actions,
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
including allowing notifications for food
contact substances to become effective;
approving food additive petitions, color
additive petitions, generally recognized
as safe affirmation petitions, and
requests for exemption from regulation
as a food additive; and approving
actions on certain food labeling citizen
petitions, nutrient content claims
petitions, and health claims petitions.
We have provided guidance that
contains sample formats to help
industry submit a claim of categorical
exclusion (CE) or an environmental
assessment (EA) to the Center for Food
Safety and Applied Nutrition (CFSAN).
The document entitled ‘‘Preparing a
Claim of Categorical Exclusion or an
Environmental Assessment for
Submission to the Center for Food
Safety and Applied Nutrition’’
identifies, interprets, and clarifies
existing requirements imposed by
statute and regulation, consistent with
the Council on Environmental Quality
regulations (40 CFR 1507.3). It consists
of recommendations that do not
themselves create requirements; rather,
they are explanatory guidance for our
own procedures in order to ensure full
compliance with the purposes and
provisions of NEPA.
The guidance provides information to
assist in the preparation of claims of CE
and EAs for submission to CFSAN. The
following questions are covered in this
guidance: (1) What types of industryinitiated actions are subject to a claim
of categorical exclusion? (2) What must
a claim of categorical exclusion include
by regulation? (3) What is an EA? (4)
When is an EA required by regulation
and what format should be used? (5)
What are extraordinary circumstances?
and (6) What suggestions does CFSAN
have for preparing an EA? Although
CFSAN encourages industry to use the
EA formats described in the guidance
because standardized documentation
submitted by industry increases the
efficiency of the review process,
alternative approaches may be used if
these approaches satisfy the
requirements of the applicable statutes
and regulations.
Description of Respondents: The
likely respondents include businesses
engaged in the manufacture or sale of
food, food ingredients, and substances
used in materials that come into contact
with food.
In the Federal Register of June 25,
2019 (84 FR 29864), we published a 60day notice requesting public comment
on the proposed collection of
information. No comments were
received.
We estimate the burden of this
collection of information as follows:
E:\FR\FM\22NON1.SGM
22NON1
]]>Agencies
[Federal Register Volume 84, Number 226 (Friday, November 22, 2019)]
[Notices]
[Page 64528]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-25351]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting.
The meeting will be closed to the public in accordance with
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C.,
and the Determination of the Director, Strategic Business Initiatives
Unit, Office of the Chief Operating Officer, CDC, pursuant to Public
Law 92-463.
Name of Committee: Safety and Occupational Health Study Section
(SOHSS), National Institute for Occupational Safety and Health (NIOSH).
Date: February 19-20, 2020.
Time: 8:00 a.m.-5:00 p.m., EST.
Place: Embassy Suites, 1900 Diagonal Road, Alexandria, VA 22314.
Agenda: The meeting will convene to address matters related to the
conduct of Study Section business and for the study section to consider
safety and occupational health-related grant applications.
For Further Information Contact: Nina Turner, Ph.D., Scientific
Review Officer, NIOSH, 1095 Willowdale Road, Morgantown, WV 26506,
(304) 285-5976; [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Control and Prevention and the
Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-25351 Filed 11-21-19; 8:45 am]
BILLING CODE 4163-18-P
